-
Omeprazole (A2845): Research Workflow Guide
2026-09-04
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, with dossier-reported activity, solubility, identity, and storage specifications. It is suitable for controlled in vitro and preclinical research workflows, but not for diagnostic, medical, or clinical use and should not be assigned dosing claims without matched evidence.
-
Hexa His Tag Peptide: Assay Design Beyond Elution
2026-09-04
Hexa His tag peptide enables clean, competitive release of His-tagged proteins from antibody-based immunoprecipitation. This article connects its chemistry to assay architecture, protein interaction analysis, and mechanistic lessons from a 2026 CARMIL–actin study.
-
Cy5 TSA Fluorescence System Kit Workflow
2026-09-03
The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright, covalently deposited Cy5 signal for difficult ICC, IHC, and FISH targets. This practical guide connects the assay to resibufogenin–NLRP3 atherosclerosis research, with optimization steps for tissue imaging, low-abundance biomarkers, and multiplex-compatible workflows.
-
U-73122: From PLC Inhibition to Invasion Assays
2026-09-03
U-73122 is a phospholipase C inhibitor for connecting calcium signaling with inflammatory responses and cancer-cell motility. This guide focuses on mechanistic assay design, interpretation, and the evidence linking PLC perturbation to myosin light-chain phosphorylation.
-
PAD4, NETs, and Translational Strategy
2026-09-02
A mechanistic and strategic guide to using Cl-Amidine as a PAD4 probe across NET biology, cancer research, inflammatory disease, and septic shock models.
-
T7 RNA Polymerase: From Template to RNA Function
2026-09-02
T7 RNA Polymerase enables precise, promoter-directed RNA synthesis for research workflows. This article connects template design and RNA quality control with lessons from inhaled RNA immunotherapy research, offering a practical framework beyond conventional protocol optimization.
-
Capillarisenol C: ER Stress and Cytotoxic Autophagy
2026-09-01
The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as an inducer of ER stress-dependent cytotoxic autophagy in HepG2 and Huh7 liver cancer cells. Its inhibitor, gene-knockdown, imaging, and signaling experiments place PERK–eIF2α and IRE1 activation upstream of the observed autophagic cell death, while 4-PBA rescue supports a mechanistic role for endoplasmic reticulum stress.
-
Isorhamnetin: Designing Mechanistic Oocyte Assays
2026-09-01
Isorhamnetin improves the interpretability of oocyte maturation studies by connecting PI3K/Akt activation with oxidative, mitochondrial, apoptotic, and endoplasmic-reticulum endpoints. This guide translates the reference findings into a decision-oriented assay framework for reproducible cellular stress research.
-
Lenalidomide and the Epigenetic Edge in Myeloma
2026-08-31
Lenalidomide (CC-5013) is more than a conventional immunomodulatory compound: its immune, anti-angiogenic, anti-inflammatory, and direct antitumor activities create a platform for studying how tumor-cell epigenetic state controls therapeutic response. New findings on DOT1L inhibition suggest a translational strategy for strengthening lenalidomide activity through innate immune reprogramming, while also defining the controls and biomarkers needed for rigorous multiple myeloma research.
-
NEDD4L, PRMT5, and Colorectal Cancer Metastasis
2026-08-31
The reference study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis and defines PRMT5 as a previously unrecognized NEDD4L substrate. Its mechanistic model links PRMT5 degradation to reduced AKT1 arginine methylation, AKT/mTOR pathway inhibition, and impaired metastatic colonization.
-
Capillarisenol C Drives ER Stress–Linked Autophagy
2026-08-30
The reference study identifies a mechanistic basis for the cytotoxicity of capillarisenol C, a bisphenol from Artemisia capillaris, in HepG2 and Huh7 liver cancer cells. Its findings connect PERK–eIF2α and IRE1 activation with autophagy-dependent cell death, while 4-PBA rescue experiments support ER stress as an important upstream driver.
-
AS1842856: A Mechanistic Foxo1 Inhibitor
2026-08-29
AS1842856 is a selective Foxo1 inhibitor for dissecting glucose production, autophagy, and pathway-dependent cell-state decisions. This article connects its direct transcription-factor inhibition to the iron-sensitive KDM4D–PI3K–Akt–Foxo1 mechanism and translates that insight into better assay design.
-
Cy5-UTP for Mechanistic RNA Imaging
2026-08-28
Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH, expression analysis, and RNA–protein studies. This guide connects Cyanine 5-uridine triphosphate chemistry with assay design lessons from MALAT1–TDP-43 research.
-
Phosbind Biotin LC: PVDF Workflow Guide
2026-08-28
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, but it is unsuitable for aqueous-only protocols and long-term storage as a working solution.
-
DNase I (RNase-free) for Clean RNA Workflows
2026-08-27
DNase I (RNase-free) supports reliable DNA removal for RNA extraction, RT-PCR, in vitro transcription, and chromatin-focused workflows without introducing RNase activity. This guide combines mechanism, practical starting conditions, controls, and troubleshooting with assay lessons from human sensory-neuron research.